Steroid hormones induce HMG1 overexpression and sensitize breast cancer cells to cisplatin and carboplatin. - Wikidata - awgldk - TriplyDB

Steroid hormones induce HMG1 overexpression and sensitize breast cancer cells to cisplatin and carboplatin.

Steroid hormones induce HMG1 overexpression and sensitize breast cancer cells to cisplatin and carboplatin.

http://www.wikidata.org/entity/Q35747835

about

HMGB1 and HMGB2 cell-specifically down-regulate the p53- and p73-dependent sequence-specific transactivation from the human Bax gene promoter HMGB1 and HMGB2 proteins up-regulate cellular expression of human topoisomerase IIalpha Physical interaction of tumour suppressor p53/p73 with CCAAT-binding transcription factor 2 (CTF2) and differential regulation of human high-mobility group 1 (HMG1) gene expression DNA and the chromosome - varied targets for chemotherapy Gene expression profiles derived from fine needle aspiration correlate with response to systemic chemotherapy in breast cancer.The implication and potential applications of high-mobility group box 1 protein in breast cancer High Mobility Group B Proteins, Their Partners, and Other Redox Sensors in Ovarian and Prostate Cancer Redox activation of metal-based prodrugs as a strategy for drug delivery HMG-D complexed to a bulge DNA: An NMR model The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs Yeast HMO1: Linker Histone Reinvented Interaction with p53 enhances binding of cisplatin-modified DNA by high mobility group 1 protein miR-23b-3p regulates the chemoresistance of gastric cancer cells by targeting ATG12 and HMGB2 High-mobility group box 1 and cancer.Vitamin e is a nephroprotectant agent in male but not in female in a model of Cisplatin-induced nephrotoxicity HMGB1-mediated autophagy promotes docetaxel resistance in human lung adenocarcinoma.HMGB1 in health and disease.Redox state-dependent interaction of HMGB1 and cisplatin-modified DNA.High-resolution mapping of genomic imbalance and identification of gene expression profiles associated with differential chemotherapy response in serous epithelial ovarian cancer.Diepoxybutane interstrand cross-links induce DNA bending.NAC1 modulates sensitivity of ovarian cancer cells to cisplatin by altering the HMGB1-mediated autophagic response.Association between follicular fluid levels of HMGB1 protein and outcomes in patients undergoing in vitro fertilization/intracytoplasmic sperm injection cycles.Molecular mechanisms of resistance and toxicity associated with platinating agents.α(V)β(3) integrin-targeted PLGA-PEG nanoparticles for enhanced anti-tumor efficacy of a Pt(IV) prodrug Binding interaction of HMGB4 with cisplatin-modified DNA.Vitamin E, Vitamin C, or Losartan Is Not Nephroprotectant against Cisplatin-Induced Nephrotoxicity in Presence of Estrogen in Ovariectomized Rat Model.A new hexapeptide from the leader peptide of rMnSOD enters cells through the oestrogen receptor to deliver therapeutic molecules.Life after death: targeting high mobility group box 1 in emergent cancer therapies.High-mobility group box 2 (HMGB2) modulates radioresponse and is downregulated by p53 in colorectal cancer cell.Multiscale modeling of double-helical DNA and RNA: a unification through Lie groups.Evidence against protective role of sex hormone estrogen in Cisplatin-induced nephrotoxicity in ovarectomized rat model.Association between the CYP11 family and six cancer types.High-mobility group box 2 is associated with prognosis of glioblastoma by promoting cell viability, invasion, and chemotherapeutic resistance Novel metals and metal complexes as platforms for cancer therapy Effects of Fennel Essential Oil on Cisplatin-induced Nephrotoxicity in Ovariectomized Rats.Monofunctional and higher-valent platinum anticancer agents.Pharmacologic and chemical adjuvants in tumor virotherapy.Nuclear functions of the HMG proteins.Effects of spectator ligands on the specific recognition of intrastrand platinum-DNA cross-links by high mobility group box and TATA-binding proteins.Oxaliplatin in the era of personalized medicine: from mechanistic studies to clinical efficacy.

P2860

Q24292041-C70AE3D5-9A0D-438B-91D3-6C4D7C8E3E74 Q24311673-97C37E84-5B66-4C70-895C-BF17FF882E8E Q24529877-CC786846-3C11-4A95-BFBB-511CB01720D3 Q24792540-21B457F0-61A8-4A83-8B8B-A7428B5A79CE Q24807351-E8C31E85-6887-45DF-ACD1-4818451FF2AD Q26744069-CB5180A3-DEDA-48E4-A14B-12C45E8A9E8E Q26774902-77BD534F-B0CC-4F1A-A8C6-9A52A8012FB5 Q27025736-AF686B51-251D-4537-A10E-602285BB2069 Q27631688-CC39DD83-FA73-4F7B-A3C9-37DE52BA8666 Q28066801-8F78FD00-0A94-43C4-9573-5104F4537110 Q28074220-178935D4-AFB6-4CBA-9D41-3B206B6491D7 Q28139455-C529F9B5-F930-4404-951B-FA2D08027888 Q28606716-B090F702-961D-49ED-B780-8E0AA5D5FB56 Q33638306-B9C73EBE-251E-4964-B47B-2FCBB3428033 Q33710810-551C3C40-95A5-4DFE-9BB1-391F34E04346 Q34017957-193A072C-9461-47CD-8A9A-83ABFE612D07 Q34622835-535F202F-A63A-4A0B-A55E-1E5C70A4993A Q34744542-C49404F6-0882-4AF3-940F-0E8C38C89963 Q34768680-8C6D7321-52CF-4F7F-BF18-C8DAD953E603 Q35608561-C1712A56-2DA1-44C3-90AB-9E8AE129BCEE Q35745292-03BCBF26-D980-4DA1-BDED-F0220BB384BA Q35754018-F4FAE3D2-F084-4723-92A7-C94406D43A1F Q35758048-084C2562-A2A7-4884-AE3E-9E4435CDD7A5 Q35981228-DFFA0A22-E1B9-4993-9F77-008AD1F06F05 Q36252519-520A5FF2-212B-4C68-9971-0A2C32E3BD5E Q36296439-70FB885A-FB9D-43BF-8C01-B4E8F060E529 Q36423194-9E6B5198-3FE4-4509-A8AD-269687CDF6C9 Q36562901-D08C54A0-9D6B-46C7-88F0-742834FDE802 Q36677697-7DAB3F4F-BBF9-4FB5-BDFF-5309F6B3F7A6 Q36801979-22B8D8AE-0AEB-455F-9A59-9B9531947701 Q36984545-E408A86F-2118-41CF-8E03-B32CE090A900 Q37001517-1418DF2C-1F60-43B7-A1F0-4160A0BF655F Q37109252-7BED80F1-A69D-4351-814B-C6AE58E8FB74 Q37137649-F4D691CD-5B16-45F6-B8DA-EC434C02A2DF Q37198928-CA888A68-4F6A-486B-B3C5-580369AFBB9E Q37282213-314A2AA7-9014-4A43-8102-B58E63D69777 Q37492540-0E7A1550-EC9C-4B7F-9B7E-88EBC5A1430A Q37596093-B83A7342-5D53-46DE-B8BB-48090731F8A8 Q38297625-CEB6CE14-B063-4DAE-A4AB-B9BB7E35040D Q38641139-C1F65743-0458-4210-B04A-109674904F08

P2860

Steroid hormones induce HMG1 overexpression and sensitize breast cancer cells to cisplatin and carboplatin.

http://www.wikidata.org/entity/Q35747835

description

2000 nî lūn-bûn

@nan

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

2000年论文

@zh

2000年论文

@zh-cn

name

Steroid hormones induce HMG1 o ...... to cisplatin and carboplatin.

@ast

Steroid hormones induce HMG1 o ...... to cisplatin and carboplatin.

@en

type

label

Steroid hormones induce HMG1 o ...... to cisplatin and carboplatin.

@ast

Steroid hormones induce HMG1 o ...... to cisplatin and carboplatin.

@en

prefLabel

Steroid hormones induce HMG1 o ...... to cisplatin and carboplatin.

@ast

Steroid hormones induce HMG1 o ...... to cisplatin and carboplatin.

@en

P1433

Q35747835-8D95CF74-A58B-4BB7-BA50-F102A2D5AD29

P1476

Q35747835-52114D6F-6C5E-42AF-9EDE-E1634EB5A48F

P2093

Q35747835-0710062B-7EA7-4169-AAF5-E5399541BDE5

Q35747835-553D04EC-8A8C-41C1-BC69-DDBE33EDDF29

Q35747835-F54FC9DA-14EC-4EC4-AC3B-6DACF87DAE82

P2860

Q35747835-0446E142-3C71-4A03-95D9-C12C1C9A9059

Q35747835-0FD41A19-1A0E-4E3E-B3C9-AC7A20D80AEE

Q35747835-16F7FB85-2C3A-4B4F-95FE-787DA52CBE1D

Q35747835-177689CB-11AB-4FB0-868F-38B1394C49FC

Q35747835-237AFEC9-52E2-4691-970E-D2E01C4A6FE2

Q35747835-4FD52168-2EFA-48A5-B9AE-B9C055093A49

Q35747835-50C0347A-9213-41E8-B54D-6A0900E8B416

Q35747835-55F83CFC-524D-4659-93A7-3171C62C9AE0

Q35747835-57DD8DEB-26BD-4C0E-98B9-FDA7A5A8EBF5

Q35747835-61964B4D-E5B3-43D6-9E88-F8BE7389DF09

P304

Q35747835-CCDEC367-8607-49AD-B8D6-CE545E4A2077

P31

Q35747835-0F78E0F9-5AB0-4B8F-90FD-1EE8E4DB40AC

P356

Q35747835-45DC9523-B44C-4DE3-9E46-7E0CE14089F4

P407

Q35747835-7E39517F-AF82-433C-898E-40DB618565A5

P433

Q35747835-C0B46B42-B8BC-4F50-A9FE-DA2FDF245D3F

P478

Q35747835-42BE777F-AA3D-42B3-878B-621D9151F2C6

P577

Q35747835-3D74D075-A408-4E96-82D5-4DE5CDC4275E

P5875

Q35747835-5520F9D2-8888-4E68-A6CA-046CF2548CAC

P698

Q35747835-B789AEB4-A7B9-4069-BF4F-CDCE044032E0

P921

Q35747835-2CE5E2FF-D60F-4280-91C6-AA46AF2337A3

P932

Q35747835-F437F7BB-1B9D-47A9-BDED-8C676E58212E

P356

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Steroid hormones induce HMG1 o ...... to cisplatin and carboplatin.

@en

P2093

He Q

http://www.w3.org/2001/XMLSchema#string

Liang CH

http://www.w3.org/2001/XMLSchema#string

Lippard SJ

http://www.w3.org/2001/XMLSchema#string

P2860

High-mobility group chromatin proteins 1 and 2 functionally interact with steroid hormone receptors to enhance their DNA binding in vitro and transcriptional activity in mammalian cells

The HMG-domain protein Ixr1 blocks excision repair of cisplatin-DNA adducts in yeast.

HMG-1 as a late mediator of endotoxin lethality in mice

The lack of chromosomal protein Hmg1 does not disrupt cell growth but causes lethal hypoglycaemia in newborn mice

Toxic effects of cis-dichlorodiammineplatinum(II) in man.

HMG domain proteins: architectural elements in the assembly of nucleoprotein structures.

Drugs five years later. Cisplatin.

Flexing DNA: HMG-box proteins and their partners.

HMG-domain proteins specifically inhibit the repair of the major DNA adduct of the anticancer drug cisplatin by human excision nuclease

Multifactorial mechanism for the potentiation of cisplatin (CDDP) cytotoxicity by all-trans retinoic acid (ATRA) in human ovarian carcinoma cell lines.

P304

5768-5772

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.100108697

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

97

http://www.w3.org/2001/XMLSchema#string

P577

2000-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12505746

http://www.w3.org/2001/XMLSchema#string

P698

10811891

http://www.w3.org/2001/XMLSchema#string

P921

P932

18508

http://www.w3.org/2001/XMLSchema#string